Health
Tennessee prison chief Frank Strada resigns after Christa Pike's botched execution
Strada said his resignation was 'in the best interest of Tennesseans' while the review is conducted and defended the state's execution process Tennessee Department of Correction Commissioner Frank Strada will resign this month following the failed execution of death row inmate Christa Pike, Governor Bill Lee announced Saturday, as the state faces growing calls for answers over the second botched execution attempt in five months.Lee also appointed former US Attorney Ed Stanton to lead an independent review of what went wrong during Pike's execution attempt on Wednesday. The governor has halted further executions while the review is under way.Strada said his resignation was “in the best interest of Tennesseans” while the review is conducted. He defended the state's execution process, saying he believed Tennessee “carried out its responsibilities in accordance with the established protocol.”Pike, 50, remained unconscious and on a ventilator in hospital after the state administered two doses of the lethal drug pentobarbital but failed to complete her execution. Her lawyers said hospital staff were trying to clear the drug from her system. There was no immediate update on her condition from her legal team on Saturday.Pike's lawyers welcomed Strada's departure but said it “does nothing to help Christa now.” “What happened to her Wednesday reflects a systemic failure that goes far beyond any one person,” the four-lawyer team said. “We hope the governor’s call for a full, independent review will expose the profound problems within Tennessee’s entire death penalty system.” Problems with IV lines blamed The execution attempt has drawn criticism from both supporters and opponents of the death penalty. Pike's lawyers said they believed problems with the IV lines caused the pentobarbital to enter her body rather than her bloodstream.Pike was reportedly cooperative as the execution team struggled to insert the IV lines. Her lawyer Randy Spivey said she even told staff, “please try here, please try here” as they attempted to place the lines. Second failed execution since May The incident was the second time since May that Tennessee stopped an execution after a prisoner appeared to be close to death. In May, officials halted the execution of Tony Carruthers after they managed to place an IV in his right arm but could not establish a second line. Lee later ordered that Carruthers not be executed again for at least a year.Stanton has previously reviewed problems with Tennessee's lethal injection process. In 2022, Lee appointed him to examine why another execution was called off. Stanton concluded that the state had failed to follow its own lethal injection procedures. Strada's record in Tennessee and Arizona Strada became commissioner of Tennessee's Department of Correction in January 2023 after serving as deputy director of the Arizona Department of Corrections. In late 2024, he announced that Tennessee would change its lethal injection protocol and use only pentobarbital.His record in Arizona has also come under scrutiny. Court filings show that Strada oversaw executions there when the state resumed carrying them out in 2022 after an eight-year pause.During the execution of Clarence Dixon that year, medical staff struggled to find a vein and eventually made an incision in his groin to administer the drugs. The process lasted about 25 minutes.Medical staff also initially struggled to find a vein during Frank Atwood's execution in 2022 before inserting an IV into his right hand. During Murray Hooper's execution later that year, an attempt to place an IV in his right arm failed, while a line inserted in his leg entered his femoral artery.“When Governor Lee hired Strada to fix execution problems in Tennessee, his problematic history of executions in Arizona was well known,” said Kit Thomas, an attorney who has represented people on Tennessee's death row.
Times of India·5 hours ago·3 min read
Health
Insurance companies want policyholders to pay 10% of health claims
The proposal, being considered by the General Insurance Council, would pair the change with common hospital empanelment and a formal mechanism for settling disputes between insurers and hospitals. MUMBAI: Non-life insurers are considering a 10% co-payment by policyholders on retail health policies from Jan 1, 2027, with the patient's contribution capped at Rs 5 lakh per claim. In return, customers would pay lower annual premiums.The proposal, being considered by the General Insurance Council, would pair the change with common hospital empanelment and a formal mechanism for settling disputes between insurers and hospitals. The arrangement would require even those with comprehensive health insurance to keep funds for medical emergencies, as they would have to pay 10% of admissible inpatient hospitalisation costs, including those arising from accidents, whether claims are settled through cashless procedure or reimbursement. Outpatient claims would remain outside scheme The proposal covers retail indemnity products, retail-under-group policies, indemnity components of combi products, internal migrations and portability business. Outpatient claims would remain outside the scheme.Co-payment cannot be waived, reduced or modified through riders or endorsements, and the customer’s 10% contribution cannot be recovered from another health insurance policy.“The choice between a cheaper policy with a deductible and a full-compensation policy should rest with the insured. People buy insurance to be indemnified for their costs. It would be unfair to customers willing to pay a higher premium for a higher sum insured to still bear part of the cost, and this could discourage them from buying high-value policies,” said Shreeraj Deshpande, a health insurance expert who earlier headed operations at a general insurer. While the industry is seeking to address what it sees as cost distortions in healthcare, some fear a mandatory requirement could be anti-competitive. “If the industry collectively decides that no one will offer a full-compensation policy, it might catch the attention of the Competition Commission,” said an industry executive.The logic behind the measure is that hospitals may order additional diagnostic tests, recommend procedures and extend hospital stays when patients have comprehensive insurance cover. Higher-category rooms can also increase total bills because doctors’ fees and procedure charges are often linked to room tariffs. Join conversation View All Comments → Share your thoughts in the comments Insightful Agree Disagree Skeptical Concerning Promising Worth Reading Big Development Post Comment Be respectful · TOI community guidelines With insurance covering the full bill, patients may have less incentive to question charges or choose lower-cost hospitals.“This behaviour (overbilling and provider-induced demand) stems from the perception that insurance-backed patients are less price-sensitive, leading to inflated healthcare costs,” a council note said.The proposal also calls for common hospital empanelment, outcome-based contracts and a payor-provider grievance forum. GI Council plans standard empanelment across more than 4,300 hospitals to set benchmark tariffs and curb arbitrary billing, while linking contracts to clinical and procedure-wise outcomes.
Times of India·7 hours ago·2 min read
Health
Indians live longer than Pakistanis, lag Bangladeshis, says WHO
The logic behind the measure is that hospitals may order additional diagnostic tests, recommend procedures and extend hospital stays when patients have comprehensive insurance cover. NEW DELHI: Indians can expect to live longer than their counterparts in Pakistan, but have shorter lives than people in Bangladesh, the US and Canada, according to the latest World Health Organization estimates.India's life expectancy at birth was 71 years in 2023, compared with 68.2 years in Pakistan, 72.7 years in Bangladesh, 78.5 years in the US and 81.4 years in Canada. But living longer does not necessarily mean living more years in good health. India's healthy life expectancy was 60.6 years in 2023, compared with 60.5 in 2019. It had fallen to 58.4 years in 2021 before recovering to 60.2 years in 2022. The figures are part of WHO's Global Health Estimates, released Friday, covering life expectancy, healthy life expectancy, causes of death and disease burden from 2000 to 2023. WHO said global life expectancy recovered close to pre-pandemic levels, while healthy life expectancy has recovered more slowly. In 2 years from 2021, India regained 2.9 years of expected lifespan: WHO For India, the difference is particularly visible over the pandemic years. Life expectancy fell from 70.5 years in 2019 to 68.1 years in 2021 before rising to 70.5 years in 2022 and 71 years in 2023. In just two years, India regained 2.9 years of expected lifespan.Healthy life expectancy, however, recovered by only 2.2 years, from 58.4 years in 2021 to 60.6 years in 2023, leaving it just 0.1 year above the 2019 level. The gap is also visible among older Indians. At age 60, a person could expect another 18.8 years of life in 2023, compared with 18.4 years in 2019. But 13.7 of those years were expected to be lived in full health, up from 13.4 years in 2019.India’s disease profile has changed sharply. Communicable diseases, such as tuberculosis and diarrhoeal infections, can spread from person to person, while non-communicable diseases (NCDs), such as heart disease, stroke and diabetes, are generally long-term conditions.In 2000, communicable diseases accounted for nearly 62% of the combined death rate from the country’s 10 leading causes, while NCDs accounted for 34%. By 2023, the pattern had reversed, with NCDs accounting for nearly 75% and communicable diseases 16% of the combined death rate from the top 10 causes. The rest was from injuries. Join conversation View All Comments → Share your thoughts in the comments Insightful Agree Disagree Skeptical Concerning Promising Worth Reading Big Development Post Comment Be respectful · TOI community guidelines The shift is evident in the leading causes. In 2000, tuberculosis and diarrhoeal diseases topped the list, with 92.4 and 87.8 deaths per 100,000 population. By 2023, ischaemic heart disease, chronic obstructive pulmonary disease, stroke and diabetes were among the leading causes, with rates of 138.5, 83.19, 74.8 and 49.01, respectively. Yet infectious diseases remain a significant burden, with diarrhoeal diseases, tuberculosis and lower respiratory infections still among India’s top 10 causes of death in 2023.Globally, the shift towards chronic diseases is also pronounced. NCDs accounted for 74% of deaths in 2023, up from 58% in 2000, while eight of the world’s 10 leading causes of death were NCDs. Global life expectancy reached 73.3 years in 2023, almost back to the 73.4 years recorded in 2019, while healthy life expectancy stood at 62.8 years, still 0.4 years below its 2019 level.
Times of India·7 hours ago·3 min read